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ABSTRACT
Kenche, Harshavardhan. M.S., Biochemistry and Molecular Biology, Wright State
University, 2008. Validation of a custom-made microarray to study human intestinal
microflora

Intestinal microflora refers to all the different species of bacteria that reside in the human
gut and is an important ‘organ’ of the human body because almost all the digestive
reactions of the host occur in the intestine. The bacteria of the intestine play a key role in
this process by supplementing the intestine with various enzymes and proteins that are
required for the digestive process. At the same time, these bacteria were shown to be
implicated in a variety of gastrointestinal disorders like Irritable Bowel Syndrome,
Inflammatory Bowel Disorder and Gastrointestinal Cancer, but with the current
knowledge about the microflora it is difficult to determine which exact species is
responsible for a particular disease caused. The knowledge about the composition of the
typical intestinal microflora is very limited, the cause at large being the lack of proper
culture techniques to isolate and study the microfloral species in artificial media.
Majority of the species of the microflora are obligate anaerobes and selective culturing
techniques provide very limited knowledge about the composition of such complex
microflora. Phylogenetic microarrays are one such approach to study various members of
the microflora because they contain probes for numerous species of bacteria on a single
glass slide and are also known to provide robust and high throughput analysis.

[iii]

ENTREZ nucleotide database was used to compile a list of 16S ribosomal DNA
(rDNA) sequences of bacterial species isolated from the human intestine and they were
grouped into various phylo-species. Representative sequences for each phylo-species
were extracted and the probes on the microarray were designed based on these
representative sequences. 16 different bacterial species were used for validation
experiments, which represented bacteria from various groups. The results showed that the
microarray correctly identified 15 of a total 16 bacterial species. The detection sensitivity
of the microarray was at least 1pg. As a test, fecal samples from adults and children were
analyzed by the microarray. Clostridia were the dominant group of the microflora
followed by Bacteroidetes in both adults and children. The analysis of the fecal samples
showed clear differences between the microflora composition of adults and children.
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1. Introduction

1.1 Microflora: Introduction
All the various groups of bacterial species that inhabit the intestine of humans are
collectively referred to as microflora. The field of intestinal microecology is as old as
medical microbiology. Much effort has been devoted towards investigation of the
indigenous intestinal flora since the beginning of the century and considerable progress
has been made in characterizing the intestinal microflora, especially in recent years with
modern methods of molecular biology, but several problems are confronted in defining
the normal intestinal microflora. The composition of the flora is quite complex,
particularly in areas where there are higher counts of bacteria such as colon (>1011
organisms per gram dry weight). Many of these organisms have fastidious growth
requirements and they require a very selective medium for. Detailed studies of the bowel
flora are extremely time-consuming. However, shortcuts lead to significant inaccuracies.
As the laboratory techniques get improvised, new species continue to be discovered.
Savage (1977) has observed that about 90% of the 1014 cells associated with
human body are microorganisms, and that the vast majority of these bacteria reside in the
large intestine. Direct microscopic estimations of bacterial numbers in the gut contents
indicate that considerably more cells are present, and that total counts increase by an
order of magnitude from the proximal end to distal end of the colon. A vast majority of
the microbes of the intestine are anaerobes but they exhibit varying degrees of tolerance
to oxygen. Anaerobic bacteria appear to outnumber the aerobic species by a factor of
about 1000.
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Research suggests that the relationship between the gut flora and host is not
merely commensal, but rather a mutualistic/symbiotic relationship. Though people can
survive with no gut flora, the latter perform a lot of useful functions like fermentation of
unused metabolites, inhibition of growth of harmful species, production of vitamins for
host and production o hormones to direct the host to store fats. However, in some
conditions, some species are thought to cause disease by causing infection or increasing
cancer risk for the host.

Normal microflora of the Stomach
It is believed that the intraluminal environment of the normal human stomach is
relatively sterile, with only few counts of organisms. Studies have shown low counts (<=
103 colonies per milliliter gastric contents) of α-hemolytic streptococci, anaerobic cocci,
lactobacilli, Staphylococcus epidermis, and Candida albicans (Giannella et al., 1972;
Franklin and Skoryna, 1966). These counts may represent oral and ingested organisms
since counts tend to decrease to zero gradually within several hours after eating.
Giannella et al. (1972) showed that the gastric pH plays a significant role in controlling
the growth of organisms in the stomach. When a marker organism (Serratia marcescens)
was introduced into the normal stomach, it was totally eliminated within half hour.
Patients with hypochlorhydria have higher bacterial counts. Patients who have undergone
surgical procedures for gastric disorders also show higher bacterial counts in the stomach,
which suggests the importance of lower gastric pH in maintaining low microbial counts.
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Normal microflora of the Small Intestine
The amount of flora encountered in the small intestine is strictly dependent of the
location of sampling. The upper small intestine is usually sterile (or has a low microbial
count) when compared to that of the lower small intestine. Gorbach et al. (1967) used a
long polyvinyl tube to sample locations throughout the small intestine and stomach.
Multiple samples taken from healthy human volunteers showed the upper small intestine
has low counts (0-104 colonies per milliliter) of both aerobic and anaerobic organisms.
An important aspect here is the complete absence of coliforms and Bacteroides. As we go
towards the distal end of the small intestine, the counts were higher (103 – 106 colonies
per milliliter), and the flora had higher counts of coliforms and Bacteroides.
A potential criticism of this type of study is that the presence of the tube itself
might alter the physiology of the bowel and change the nature of the flora. Another
important observation was the relationship between the gastric pH and the microfloral
count. Subjects with higher gastric pH had higher counts of both anaerobes and aerobes
in the midintestinal aspirates. This supports the concept that gastric acid acts as a barrier
to the swallowed organisms (Drasar et al. 1969).

Normal microflora of the Large Intestine
Several problems are encountered when trying to study the composition of the
microflora in large intestine. Bacterial counts vary throughout the large bowel, and the
numbers found in fecal specimens may not accurately represent the counts found in other
locations of the colon. Bentley et al. (1972) studied patients undergoing elective
cholecystectomy and compared the microflora of the transverse colon, cecum and
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terminal ileum with the microflora of the stool specimens. The highest bacterial counts
were obtained from stool specimens; the mean anaerobic count was 109 colonies per
gram, and the mean coliform count was 107 colonies per gram. Bacterial counts in the
terminal ileum were even lower with relatively fewer anaerobes. Although there were
substantial numerical differences in the counts of bacteria between stool samples and
samples from various locations in the large intestine, there did not appear marked
qualitative differences in the flora. Dominant species found in this part of the human gut
are Clostridia and Bacteroides.

Effect of diet and age on normal intestinal microflora
Many factors influence the composition of normal intestinal microflora. Normal
individuals, when on a chemically defined diet, show a marked reduction in the number
of organisms in their stool. Fewer studies were performed on the relationship between the
age and microflora of an individual. The changes that occur in the intestinal microflora
when a newborn is weaned and introduced to solid food are most likely due to the effect
of change in diet rather than change in the age. The fecal flora of children appears to
closely resemble that of adult fecal flora by the age of 1 year. Ellis-Pegler et al. (1975)
noted that the concentration of aerobes (particularly streptococci and gram-negative
facultative bacilli) decreased during the first year of life and anaerobes (particularly
Bacteroides) became the predominant members of the fecal flora.
The effect of advanced age on the intestinal microflora in the adult is another area
where few data exists. Gorbach et al. (1975) found that elderly subjects harbored fewer
bifidobacteria but larger number of fungi and coliforms than younger subjects. These
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results were in agreement with studies done by other investigators. However, relatively
small number of patients have been studied and considerable variation existed among
individuals of the same age.

1.2 Metabolic activities of the Intestinal Microflora

Low molecular weight carbohydrates
Most of the simple sugars and disaccharides that are consumed by the host do not
reach the colon because they are absorbed as they pass through the small intestine.
However, small amounts of few simple sugars may reach the colon. Moreover, the
amount of simple sugars that escape digestion in the small intestine may depend on
whether the sugars are ingested in a mixture along with complex carbohydrates. For
example, certain types of polysaccharides can decrease the rate of glucose absorption
from the small intestine (Holt et al., 1979; Schwarz and Levine, 1980). Thus, it is
possible that small amounts of few simple sugars or disaccharides in foods reach the
colon.

Dietary polysaccharides
Dietary fiber, which are plant cell wall polysaccharides, comprise a significant
portion of many human foods. Nutritional studies have indicated that most of the dietary
fiber is not excreted. As the human intestinal enzymes cannot degrade plant cell wall
polysaccharides, the degradation of dietary fiber has been attributed to fermentation by
colonic bacteria. Since at least 50% of dietary fiber is digestible by colonic bacteria (Van
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Soest, 1978), the carbohydrate in dietary fiber could provide a substantial portion of the
resources needed to maintain the bacterial mass in the colon.
Previous studies have shown that members of Bacteroides are most active
fermenters of plant polysaccharides. Members of the genus Bacteroides account for about
20% of all fecal isolates (Moore and Holdeman, 1974; Holdeman et al., 1976). But it is
incorrect to conclude that most of the catabolism of dietary fiber is done by Bacteroides
as the studies have been done using pure cultures and the isolated polysaccharides in
artificial medium, and thus they may not take into account many of the factors that are
inherent in the actual gut environment.

Polysaccharides produced by the host
The host itself produces complex carbohydrates that can be utilized by the colon
bacteria. In rats and presumably in humans, the intestinal mucosa is completely replaced
once in every 4-5 days (Lipkin, 1973). In addition to the mucosal cells which are
constantly given out into the intestinal lumen, the host produces large amounts of saliva,
gastric juice and mucinous secretions, all of these products contain glycoproteins, and
there is some evidence that host products are utilized by microflora in vivo. Hoskins and
Boulding (1976) have shown that human fecal homogenates can degrade blood
glycoproteins. The organisms responsible for this have not been isolated and identified,
but Miller and Hoskins (1981) have estimated that these organisms account for 1% of the
total population of bacteria in the colon.

6

Biotransformation of Bile acids and Cholesterol
The intestinal microflora of man and animals can transform bile acids and
cholesterol into a variety of metabolites (Hayakawa, 1973). Known microbial
biotransformations include hydrolysis of conjugated bile acids to yield free acids
(Hylemon et al., 2006). The extent of degradation is limited by the constraints inherent in
the strictly anaerobic environments of the colon. In man, the microflora can generate at
least 15-20 different bile acids from the primary bile acids. The biotransformation
markedly alters the physical characteristics as well as the physiological effects of steroid
molecules.

1.3 Gastrointestinal disorders
Metchnikoff (1907) suggested that bacteria inhabiting the human intestine
affected health and longevity of the host. Most of the diseases that occur in the human
intestine are of unknown origin, but bacteria have been shown either as causative agents
or maintenance factors involved in many colonic disorders. A number of species are able
to upset the normal gut homeostasis and cause an acute inflammatory response. The
principal organisms involved are enterotoxigenic strains of Escherichia coli, as well as
species belonging to genera Salmonella, Shigella, Campylobacter, and Yersinia.
Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS) are thought to
have an origin connected with the activities of gut flora.
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1.3.1 Inflammatory Bowel Disease
Two major instances of Inflammatory Bowel Disease are Ulcerative Colitis (UC)
and Crohn’s disease (CD). Both conditions involve an inflammatory reaction and share
many clinical features, which make individual diagnosis difficult. Marked difference is
that CD affects primarily the small intestine and all regions of large intestine, whereas
UC usually affects the distal colon (Whitehead 1989).
Ulcerative Colitis
The inflammatory response of UC is primarily located in the colonic
mucosa and sub mucosa. The distal colon is always affected with the condition
expressing itself in acute attacks followed by periods of symptom free remission.
Bacterial involvement has been suggested in both initiation and maintenance
stages of UC (Hill 1986). Streptococcus mobilis, Fusobacteria and Shigella have
been attributed as specific causative agents (Onderdonk 1983, Campieri 2001),
largely because these organisms are either able to penetrate the gut mucosal
epithelium or cause similar disease symptoms in animals. More direct and
convincing evidence exists for a bacterial role in disease maintenance
(Cummings et al., 2003).
Crohn’s Disease
According to Chadwick (1991), Eubacterium, Peptostreptococcus,
Pseudomonas, Bacteroides vulgates and Clostridium difficile are associated with
the onset of Crohn’s disease. Because this particular disease involves a
granulomatous reaction, it is more likely that a persistent stimulus is involved.
Mycobacteria are thoroughly studied in this respect and M. paratuberculosis has
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been isolated from a number of CD patients (Chidoni et al., 1984; Gitnick et al.,
1985, Graham et al., 1987, Greenstein 2003).

1.3.2 Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by
abdominal pain, discomfort, bloating and cramping, relieved by defecation and alteration
of bowel habits. IBS may also be predominated by diarrhea (IBS-D) or constipation (IBSC) or both may alternate (IBS-A). However, the symptoms may vary from person to
person. Some people have constipation, and report straining and cramping when trying to
have a bowel movement but cannot eliminate any stool or able to eliminate only a small
amount. People with diarrhea frequently feel an urgent and uncontrollable need to have a
bowel movement. Other people with IBS alternate between constipation and diarrhea.
Some people find that their symptoms subside for a few months and reoccur after a while
whereas other people report a constant worsening of the symptoms over time.
The specific cause of IBS is yet to be discovered. One theory states that people
who suffer from IBS have a large intestine that is particularly sensitive and reactive to
certain foods and stress. The immune system may also be involved. Normal motility may
not be present in the colon of a person suffering from IBS. It can be spasmodic or even
stop working temporarily. The epithelial lining of the colon regulates the flow of fluids in
and out of the colon. In IBS, the function of the epithelium appears normal but the
contents inside the colon move too quickly for the colon to absorb the fluids. The result is
too much fluid in the stool. In other people, the movement occurs slower than the normal
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rate which results in extra fluids being absorbed from the contents passing through the
colon which results in the person developing constipation.
Research publications from the later 1990s began identifying the biochemical
changes present in the tissue and serum samples from IBS patients (Talley et al., 1999,
Thompson et al 1999, Saito et al 2002). These studies identified cytokines and secretory
products in tissues taken from IBS patients. A study done on the biopsy samples from
constipation predominant IBS patients showed elevated levels of serotonin-a
neurotransmitter. Ninety five percent of the serotonin in the body is located in the GI tract
and rest is found in brain. Cells that line the inside of the bowel work as transporters of
serotonin and carry it in and out of the GI tract. People with IBS have diminished
receptor activity, causing abnormal levels of serotonin in the GI tract. As a result, they
experience problems with bowel movement, motility and sensation--having more
sensitive pain receptors in their GI tract.
A study on the rectal biopsy tissues from IBS patients showed increased levels of
cellular structures involved in the production of Interleukin 1-β (K-A Gwee et al., 2003).
Studies on blood samples from IBS patients showed increased levels of TNF-α,
Interleukin 1 and Interleukin 6.

1.4 Existing methods to diagnose the GI disorders
GI disorders are extremely difficult to diagnose because of the characteristic
symptom overlap among common ailments (like diarrhea). The patient may show no
symptoms, even if the bowel becomes increasingly damaged for years. Once the
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symptoms start to show up, they often resemble those of other conditions, making the
diagnosis difficult.
The doctor may go through the ‘medical history’- consisting of the patient’s past
health, family’s health, any medications he/she is taking, any allergies the patient may
have and other related issues. Blood tests may be done to determine the signs, if any, of
the inflammation in the body which are often present with the disease. Analysis of the
stool sample may be done. Colonoscopy may be done to see inflammation, bleeding or
ulcers on the wall of the colon.

1.5 New and efficient ways to study Microflora
Previous studies of the microflora were usually done by culturing the fecal
samples or the biopsy samples on various kinds of defined media which are specific for
certain bacterial species. But the drawback in such kind of study is that only limited
number of microfloral species can be studied. Detailed studies of the microflora using
such an approach are extremely time consuming and difficult. However, shortcuts lead to
significant inaccuracies.
The advent of new techniques in PCR amplifications, particularly those which use
16S rDNA as a phylogenetic classifier (Wang Q et al., 2007) helped to great extent to
identify most of the unclassified species of the microflora. 16S rDNA is believed to be an
important phylogenetic classifier because it is believed to be conserved from an
evolutionary point of view. Many of the members of the microflora are believed to exist
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only on the basis of their 16S rDNA sequence and were never cultured in a laboratory
due to the lack of proper culture techniques.
Microarray technology is another powerful tool that can be used to detect
thousands of genes/target sequences in a large population. Oligonucleotide probes that
are complimentary to the 16S rDNA sequences of various species can be synthesized
directly on the glass slide. The sample population is hybridized to the microarrays to
interrogate the presence of species of interest. Microarrays provide advantages over the
PCR amplification studies because of the robust and high throughput analysis.
The advantage of oligonucleotide microarrays is the use of photolithographic
process, by which dense arrays are produced containing numerous copies of a large
number of different probes in a small area. This allows each array to contain considerable
probe redundancy and internal standards to evaluate hybridization efficiency (Graves,
1999). The oligonucleotide array also allows for discrimination based on single base pair
differences (Nuwaysir et al., 1999). This allows the oligonucleotide arrays to be applied
in fields of medical diagnosis, pharmacogenetics and sequencing due to their
hybridization and gene expression analysis capabilities.
Various kinds of microarrays have been used to study the fecal microbial
composition including community genome arrays, functional genome arrays, and
phylogenetic oligonucleotide arrays. Of these, the phylogenetic oligonucleotide arrays are
best suited to study the microflora because their probe sequences are based upon the
ribosomal RNA sequences and are ideal for microbial community composition studies.
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For our study purpose, we have chosen microarrays manufactured by Affymetrix
Inc. (Santa Clara, CA) (Affymetrix Technical Note 2001). The advantages of the
Affymetrix based microarrays include:
•

Constructed with a very high precision and accuracy.

•

Have a high probe density, sensitivity and specificity.

•

The use of Perfect Match (PM) and Mismatch (MM) probe pairs offers
higher selectivity at low target concentrations.

•

Use of multiple probes per sequence or gene allows statistical algorithms
to provide confidence in microarray results.

•

Probes for many different rDNA genes can be synthesized on a single
array and thus hundreds of species can be tested in each microfloral
sample.

1.6 Design of custom-made Microarray
The design of the custom-made microarray was carried out by Dr. Oleg Paliy in
collaboration with Dr. Qiong Wang and Dr. Jim Cole of Ribosomal Database Project at
Michigan State University. The probes of the microarray were based on the 16S rDNA
sequences of various bacterial species that are believed to inhabit the human gut. A list of
16S rDNA sequences of intestinal microflora was compiled by performing a search of
Entrez Nucleotide Database by using the following search string:
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“(SSU OR 16S OR small subunit) AND (rRNA OR rDNA OR ribosomal RNA
OR ribosomal DNA) AND (bacteri* OR prokaryot* OR eubacteri*) AND (human
OR sapiens OR humam) AND (GI OR colon* OR mucous OR intestin* OR fecal
OR feces OR faec* OR stool) NOT (archae* OR oral OR esophag*) AND
1200:1700[SLEN]”

The length of sequences retrieved was limited to 1700 base pairs. The search
returned a total of 15735 microbial sequences which are reported to inhabit the human
intestine. Manual examination of all the sequences revealed that the compiled list was
highly redundant and hence the task of narrowing down the list into smaller groups was
done. The initial dataset of 15735 sequences was grouped into various “Phylo-species”which share a 98% sequences similarity among them. This grouping was done so that any
newly discovered sequence(s) would fall into any one of the phylo-species.
The representative sequences of all the phylo-species were constructed and were
truncated in such a way that the 16S rDNA sequence would fall between nucleotide
positions 28 and 1491 (E.coli 16S rDNA positions) because this region can be amplified
using universal 16S rDNA PCR primers. The truncated file was saved and supplied to
Affymetrix design team as in input for their algorithm. The probe length was restricted to
25 nucleotides. The minimum number of probes per probeset was 5 and the maximum
was 11. As controls, standard human, rat and mouse were included on the array. The
human controls serve to estimate the amount of contaminating human DNA and the
mouse and rat controls serve as negative controls.
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Table 1.6.1 Distribution of bacterial 16S rDNA sequences into various phylo-species

Class
Cyanobacteria
Alphaproteobacteria
Betaproteobacteria
Gammaproteobacteria
Deltaproteobacteria
Epsilonproteobacteria
Clostridia
Mollicutes
Bacilli
Actinobacteria
Spirochaetes
Bacteroides
Fusobacteria
Verrucomicrobiae
Lentisphaerae
Total

No. of phylo-species
1
9
17
11
4
6
527
12
24
29
4
126
3
1
1
775

In table 1.6.1, the number of phylo-species represents the number of bacterial
species 16S rDNA sequences that belong to a particular class and have been known to
reside in the human gut. Clostridia are the dominant members of the human microflora
followed by Bacteroides.

1.7 Thesis overview
The work in this manuscript describes the validation of the custom made
microarray. The validation experiments were done using 16 different pure bacterial
cultures that were obtained from ATCC as frozen stocks. Nucleic acids were isolated
from each bacterial species and PCR amplification of the 16S rDNA was carried out. The
use of total genomic DNA, PCR-amplified 16S rDNA and total RNA as starting material
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for hybridization was validated. The detection limit of the microarray when total gDNA
and amplified 16S rDNA was used was determined. Fold change experiments were done
to establish a relationship between the expected and observed signal ratios. Finally, as
confirmatory tests, 4 fecal DNA samples from healthy volunteers-two from children and
two from adults-were analyzed by the microarray to examine the quantitative differences
between adults and child microflora composition.
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2. MATERIALS AND METHODS

2.1 Choice of bacterial strains
Before the microarray can be put to actual experimental usage, its ability to
correctly identify different bacterial species has to be validated. For this purpose, a total
of 16 different bacterial species have been chosen so that they1. Are available as frozen stocks from ATCC (American Type Culture Collection)
2. Are culturable
3. Represent bacteria with different GC content
4. Represent bacteria from various classes.

Table 2.1.1 List of bacterial species used for validation experiments
ATCC
Number
27539
15707
25559
27274
4356
8483
8492
9689
638
9714
19403
8486
27210
51649
25586
25922

Bacterial species

Group

Bifidobacterium catenulatum
Bifidobacterium longum
Eggerthella lenta
Enterococcus faecalis
Lactobacillus acidophilus
Bacteroides ovatus
Bacteroides uniformis
Clostridium difficile
Clostridium paraputrificum
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Ruminococcus albus
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli

Actinobacteria
Actinobacteria
Actinobacteria
Bacilli
Bacilli
Bacteroidetes
Bacteroidetes
Clostridia
Clostridia
Clostridia
Clostridia
Clostridia
Clostridia
Mollicutes
Fusobacteria
Gammaproteobacteria
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GC
content
~60
60
30-40
37
35
~43
~43
29
~32
~33
~34
30-40
~42
38
27
51

Gram
+ve/-ve
positive
positive
positive
positive
positive
negative
negative
positive
positive
positive
positive
positive
negative
positive
negative
negative

The strains were obtained as frozen cultures from ATCC and stored at -800C until
final use. The cells were grown either in 15ml centrifuge flasks or T-25 tissue culture
flasks. Aerobic cultures were grown in water shaker at 370C until desired OD600 is
reached. Anaerobic were grown in sealed GasPak bag with a gas generator packet (BD
GasPak EZ) until sufficient density of cells is reached. Then the cells were spun down,
washed in ice-cold PBS (40C), centrifuged, and then frozen at -800C.

2.2 Isolation of nucleic acids
The nucleic acids were obtained from all the cell cultures using ZR
Fungal/Bacterial DNA Isolation Kit (Zymo Research) as per the following protocol:
a. Weigh about 100 mg of pellet and resuspend in 200ul of PBS.
b. Add 750 µ l of lysis buffer supplied with the kit.
c. Transfer the contents into a ZR BashingBead™ Lysis Tube and vortex at
maximum speed for 5 min.
d. Centrifuge the ZR BashingBead™ Lysis Tube in a micro centrifuge at
10,000 x g for 1min.
e. Transfer 400 µl of supernatant onto Zymo-Spin™ IV Spin Filter in a
collection tube and centrifuge at 7,000 rpm for 1min.
f. Add 1,200 µl of Fungal/Bacterial DNA binding buffer to activate the filtrate
in the collection tube.
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g. Transfer 800 µl of the filtrate in above step to Zymo-Spin™ IIC Column in a
collection tube and centrifuge at 10,000 x g for 1 min. Discard the flow
through and repeat the step.
h. Add 200 µ l of DNA prewash buffer to the Zymo-SpinTM IIC column in a new
collection tube and centrifuge at 10,000 x g for 1 min.
i.

Add 500 µl of Fungal/Bacterial DNA Wash Buffer to the column and
centrifuge at 10,000 x g for 1min.

j.

Transfer the Zymo-SpinTM IIC column to a clean 1.5 ml centrifuge tube and
elute the DNA in 100 µ l of nuclease-free H2O by centrifuging at 10,000 x g
for 30 seconds.

The nucleic acids were isolated following the above protocol. The DNA was
resuspended in nuclease-free water and the absorbance was measured using a
spectrophotometer to estimate the amount of DNA obtained from the pellets. A 1%
agarose gel was run to check the purity and integrity of the nucleic acids isolated from all
the bacterial species.
The above two steps, i.e., culturing of the species and isolation of nucleic acids
from the cell pellets, were performed by Dr. Frank Abernathy at Dayton Children’s
Hospital.

2.3 PCR amplification of 16S rDNA
The amplification of 16S rDNA was carried out from all species by using two
primers

Amp_27F

[AGAGTTTATC(C/A)TGGCTCAG]

19

and

Bact_1492R

[TACGG(C/T)TACCTTGTTACGACTT] , which are considered universal for most
bacterial species. The reaction was carried out in 50 µl volume using Takara PrimeStar
HotStart DNA Polymerase. Seventy five nanograms of pure bacterial DNA was used as
starting material and the reaction was carried for 25 cycles.
Table 2.3.1 Reaction mixture for PCR amplification of 16S rDNA
Component
DNA template
Primer-1 (100 µM)
Primer-2 (100 µM)
2.5 mM dNTP Mix
DNA Polymerase
Nuclease free H2O
Total reaction volume

Amount
75ng
1 µl
1 µl
4 µl
1 µl
up to 50 µl
50 µl

The amplified DNA was purified using Qiagen QIAquick PCR purification kit.
The purified DNA was resuspended in nuclease-free water and the absorbance was
measured using a spectrophotometer to estimate the nucleic acid yield. A 1% agarose gel
was run to check the presence of a single band at 1500 basepairs position and confirm the
amplification was correct and also to check the integrity of the sample.

2.4 Fragmentation of the amplified DNA
For hybridization onto the microarrays, fragmentation of the nucleic acids has to
be performed to reduce the size of the DNA fragments to 100-300 basepairs (bp). A
series of fragmentation experiments were performed to check for the concentration of
DNase I enzyme that would give us the desired range of fragment length. It has been
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determined that 0.075 U enzyme/µg of DNA produced the optimum range of fragments.
The fragmentation was performed by incubating the DNA with reaction buffer and
DNase I enzyme at 37oC for 10 min, followed by inactivation of the enzyme at 98oC for
another 10 min. The fragmentation was verified for proper fragment size by running the
fragmented sample on a 10% polyacrylamide gel.

2.5 Terminal labeling of the fragmented DNA
The fragmented DNA product was end-labeled with biotin in a terminal
transferase reaction following standard Affymetrix protocol.
Table 2.5.1 Labeling reaction mixture
Component

Amount

fragmented DNA
10X Reaction buffer
Genechip Labeling reagent
Terminal Transferase
Nuclease-free H2O
Total reaction volume

as required
10 µl
2 µl
2 µl
up to 50 µl
50 µl

The reaction mixture was prepared as described in Table 2.5.1 and was incubated
at 370C for 60 min. The labeling was stopped by adding 2 µl of 0.5 M EDTA. The labeled
product was ready to be hybridized onto the microarrays or alternately would be stored at
-200C for future use.

2.6 Hybridization onto the microarrays
The hybridization solution was prepared as described below:
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Table 2.6.1 Hybridization mix
Component

Amount

2X Hybridization buffer
3 nM Control oligos
10 mg/ml Herring Sperm DNA
50 mg/ml BSA
100 % DMSO
Fragmented and labeled DNA
Total volume

65 µl
2.2 µl
1.3 µl
1.3 µl
10.2 µl
up to 50 µl
130 µl

The probe array was equilibrated to room temperature immediately before use.
The indicated amount of hybridization solution mixture was added to the probe array.
The hybridization oven was preheated to 450C and the array was hybridized at the set
temperature for 16 hours. After 16 hrs of hybridization, the hybridization cocktail from
the probe array was removed and was replaced completely with appropriate volume of
Non-Stringent Wash Buffer. The staining and washing solutions were prepared on the
day of washing. Using the appropriate protocol for washing and staining of the probe
array in the fluidics station, it was properly processed and scanned using a GeneChip
Scanner 3000.

2.7 Isolation of DNA from fecal samples
DNA from fecal samples was isolated by Dr. Frank Abernathy at Dayton
Children’s Hospital using ZR Fecal DNA Kit (Zymo Research) following the protocol
supplied by the manufacturer:
1. Add up to 150 mg of fecal sample to a ZR BashingBead™ Lysis Tube. Add 750 µl
Lysis Buffer to the tube.
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2. Secure in a bead beater fitted with a 2 ml tube holder assembly (e.g., Disruptor
Genie™) and process at maximum speed for 5 minutes.
3. Centrifuge the ZR BashingBead™ Lysis Tube in a microcentrifuge at ≥10,000 x g for
1 minute.
4. Transfer up to 400 µl supernatant to a Zymo-Spin™ IV Spin Filter (orange top) in a
Collection Tube and centrifuge at 7,000 rpm (~7,000 x g) for 1 minute.
5. Add 1,200 µl of Fecal DNA Binding Buffer to the filtrate in the Collection Tube from
Step 4.
6. Transfer 800 µl of the mixture from Step 5 to a Zymo-Spin™ IIC Column in a
Collection Tube and centrifuge at 10,000 x g for 1 minute.
7. Discard the flow through from the Collection Tube and repeat Step 6.
8. Add 200 µl DNA Pre-Wash Buffer to the Zymo-Spin™ IIC Column in a new
Collection Tube and centrifuge at 10,000 x g for 1 minute.
9. Add 500 µl Fecal DNA Wash Buffer to the Zymo-Spin™ IIC Column and centrifuge
at 10,000 x g for 1 minute.
10. Transfer the Zymo-Spin™ IIC Column to a clean 1.5 ml microcentrifuge tube and
add 100 µl DNA Elution Buffer directly to the column matrix. Centrifuge at 10,000 x g
for 30 seconds to elute the DNA.
11. Transfer the eluted DNA from Step 10 to a prepared Zymo-Spin™ IV-HRC Spin
Filter (green top) (see above) in a clean 1.5 ml microcentrifuge tube and centrifuge at
exactly 8,000 x g for 1 minute. The filtered DNA is now suitable for PCR and other
downstream applications.
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3. RESULTS
3.1 Isolation of total genomic DNA from the bacterial species
Genomic DNA was isolated from all the 16 bacterial species using ZR
Fungal/Bacterial DNA Isolation Kit (Zymo Research). A 1% agarose gel was run to
check the purity and integrity of the nucleic acids.

Figure 3.1.1: 1% Agarose gel of all bacterial genomic DNAs.
Each lane in the gel was loaded with 2 µl of genomic DNA sample. 1 µl of 2-log
DNA ladder from NEB was used as size markers. The lanes on the gel correspond to:
A: Holdemania filiformis, B: Ruminococcus albus, C: Eggerthella lenta, D: Bacteroides
uniformis, E: Enterococcus faecalis, F: Lactobacillus acidophilus, G: Clostridium
paraputrificum, H: Clostridium difficile, I: Clostridium sordellii, J: Clostridium
sphenoides, K: Bacteroides ovatus, L: Eubacterium limosum, M: Bifidobacterium
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longum, N: Bifidobacterium catenulatum, O: Fusobacterium nucleatum, P: Escherichia
coli.
Figure 3.1.1 shows that all the species gave good amounts of nucleic acids except
Ruminococcus albus, which had a low yield. Hence, it was not used extensively in our
experiments.

3.2 Identification of individual species by the microarray
Initially, we wanted to test whether the microarray can correctly identify
individual species when pure gDNA from each species was hybridized to individual
microarrays. For these experiments, 250 ng of gDNA from individual species were taken
and were fragmented with 0.075 U/µg of DNase I. The fragmentation product was
visualized by running on a 10% polyacrylamide gel to make sure that we obtained desired
fragment length. The fragmented product was then end labeled with biotin in a terminal
transferase reaction and the biotin-labeled product was hybridized onto microarrays. Only
one bacterial species was used per microarray.
We wanted to determine the optimum values of concentration of the DNase I
enzyme and the time of fragmentation required. Experiments were done with various
concentrations of DNase I enzyme and various incubation times and the fragmented
products were run on a 10% polyacrylamide gel to visualize the fragmented product. All
of the fragmented product was loaded onto the gel. Five microlitres of Tri-dye ladder
(100bp-1500bp) from NEB were loaded onto the gel and used as DNA fragment size
markers. We wanted most of the fragments to fall in the range of 100-300bp.
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Figure 3.2.1 10% polyacrylamide gel of the experiments to determine optimum
concentration of the DNase I enzyme and time of fragmentation. ‘Un’ represents the
unfragmented total genomic DNA sample. L corresponds to the Tri-dye ladder from
NEB. The samples to the right of the ladder represent the various concentrations of
the DNase I enzyme in U/µg of sample and the numbers in parenthesis below the
concentrations denote the time of fragmentation.
From the figure 3.2.1, 0.075 U/µg of DNA gave the ideal fragment size. Hence
this concentration of the DNase I enzyme is used as standard concentration and is used in
all further experiments which involve the fragmentation of the total genomic DNA
sample for hybridization onto the microarrays. For the experiments where fragmentation
of the PCR-amplified 16S rDNA is used, DNase concentration of 0.04 U/µg of DNA was
used because the 16S rDNA is 1500 bp long and the use of higher concentrations may
lead

to

overfragmentation

of
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the

nucleic

acid

sample.

Table 3.2.1 Identification of individual species by microarray when total gDNA was used

Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli

Expt 1
Expt 2
Expt 3
Expt 4
Expt 5
Expt 6
Expt 7
Expt 8
Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det
250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng A
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal

Continued on next page…
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Table 3.2.1 Identification of individual species by microarray when total gDNA was used (continued)

Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli

Expt 9
Expt 10
Expt 11 Expt 12
Expt 13
Expt 14
Expt 15
Expt 16
Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal
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From Tables 3.2.1, the microarray correctly identified 15 of the total 16 bacterial
species used. Eggerthella lenta was called absent. We then wanted to see whether the
microarray can detect individual species when all the nucleic acids were pooled together.
100ng of gDNA from each individual species (except Ruminococcus albus) were pooled
into a mixture. The mixture was fragmented with 0.075U/µg of DNase I. The fragmented
product was end labeled with biotin in a terminal transferase reaction and hybridized onto
the microarray.

Figure 3.2.1 shows the scanned image of the microarray when all the samples
were pooled together. Table 3.2.4 shows the detection of the individual species when all
the gDNAs were pooled together. The microarray correctly identified 15 out of a total of
16 individual species when all the pure gDNAs were pooled together into a mixture.
Eggerthella lenta was called absent.
Figure 3.2.2: Scanned image of the microarray experiment where all the gDNAs
were pooled together and hybridized onto the microarray
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Table 3.2.2: Detection of individual species when all the gDNAs were pooled
together

Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli

Amt Det
100ng P
100ng P
100ng A
100ng P
100ng P
100ng P
100ng P
100ng P
100ng P
100ng P
100ng P
100ng P
100ng P
100ng P
100ng P

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal

3.3 PCR amplification of 16S rDNA
The near full length of 16S rDNA was amplified from all the bacterial species
using two universal (phylogenetically conserved) primers- Amp_27F and Bact_1492R,
which bind to conserved regions of the 16S rDNA gene. 75ng of gDNA was used as
starting material in each case and the amplification was carried out for 25 cycles. The
reaction products were purified using Qiagen PCR Purification Kit and the purified
product was run on a 1% agarose gel to check the size of the amplified band and also the
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integrity of the samples. Two microlitres of amplified 16S rDNA sample was loaded onto
the gel.

Figure 3.3.1: 1% Agarose gel of PCR amplification of 16S rDNA
A: Holdemania filiformis, C: Eggerthella lenta, D: Bacteroides uniformis, E:
Enterococcus faecalis, F: Lactobacillus acidophilus, G: Clostridium paraputrificum, H:
Clostridium difficile, I: Clostridium sordellii, J: Clostridium sphenoides, K: Bacteroides
ovatus, L: Eubacterium limosum, M: Bifidobacterium longum, N: Bifidobacterium
catenulatum, O: Fusobacterium nucleatum, P: Escherichia coli.
In the above figure, the control represents the unamplified total genomic DNA. 1
µl of 2-log DNA ladder (NEB) was used as DNA size markers and a nucleic acid band
that corresponds to size of 1500 basepairs can be seen in all the lanes. This is the 16S
rDNA from each species and it shows that the universal primers were effective in
amplifying the 16S rDNA from all the bacterial species tested.
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The amplified DNA is smaller in length (1.5Kb) than average fragment size of
isolated genomic DNA and as a result was fragmented with 0.04 U/µg of DNase I
because prior experiments showed that this concentration of the enzyme gave the
optimum fragment size for hybridization onto the microarrays. A part of the fragmented
product was run on a 10% polyacrylamide gel to check whether the fragmentation
worked or not.

Figure 3.3.2: 10% Polyacrylamide gel for Fragmentation-I
1/10th of the fragmentation mixture was run on a 10% polyacrylamide gel to check the
size of the fragments obtained. L: Tridye DNA ladder 100bp-1500bp (NEB) – used as
DNA size markers
A: Holdemania filiformis, B: Ruminococcus albus, C: Eggerthella lenta, D: Bacteroides
uniformis, E: Enterococcus faecalis, F: Lactobacillus acidophilus, G: Clostridium
paraputrificum, H: Clostridium difficile
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Figure 3.3.3: 10% Polyacrylamide gel for Fragmentation-II
L: Tri-dye DNA ladder 100bp-1500bp (NEB) – used as DNA size markers.
I: Clostridium sordellii, J: Clostridium sphenoides, K: Bacteroides ovatus, L:
Eubacterium limosum, M: Bifidobacterium longum, N: Bifidobacterium catenulatum, O:
Fusobacterium nucleatum, P: Escherichia coli
The fragmented products were end labeled with biotin in a terminal transferase reaction
and hybridized onto microarrays. Only one sample was hybridized per array.
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Table 3.3.1 Identification of individual species by microarray when 16S rDNA was used

Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli

Expt 1
Expt 2
Expt 3
Expt 4
Expt 5
Expt 6
Expt 7
Expt 8
Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det
250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng A
A
A
A
A
A
P
A
A 250ng P
A
P
A
A
A
A
M
A 250ng P
A
A
A
A
M
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A
A 250ng P
P
A
A
A
A
A
A
A
P
A
A
A
A
A
A
A
M
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal

Continued on next page
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Table 3.3.1 Identification of individual species by microarray when 16S rDNA was used (continued)
Expt 9

Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli

Expt 10

Expt 11

Expt 12

Expt 13

Expt 14

Expt 15

Expt 16

Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
P
A
A
A
A
P
A
A
A
A
A
M
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
M
A
A
250ng P
A
P
P
A
A
A
A 250ng P
M
P
A
A
A
A
P 250ng P
A
A
A
A
A
P
A 250ng P
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A 250ng P
A
A
A
A
A
A
A 250ng

Det
A
M
A
A
A
A
A
A
A
A
A
A
A
A
A
P

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal
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From the above results, it can be seen that 15 of a total of 16 species were
correctly identified when amplified 16S rDNA was used, except in case of Eggerthella
lenta which was again called absent. This will be discussed in the next section. It can be
seen that there were a few cases where the target sequence cross-hybridized to probes of
other species. There were cross hybridizations of the targets to probes of other species,
for example, in Expt 1, Bacteroides and Clostridia were also called present. These cross
hybridizations were shown to be reduced by the use of replicates. For example, the
experiment in which amplified 16S rDNA from Clostridium sphenoides was hybridized
onto the microarray, the DNA from that species cross hybridized to 21 other probes. The
same experiment was repeated again exactly as it was done before.
Table 3.3.2 Experiment to test reduction of cross hybridization using replicates
Clostridium sphenoides
original experiment
S051_Clostridium_x_at
S052_Clostridium_at
S052_Clostridium_x_at
S054_Clostridium_at
S087_Anaerotruncus_x_at
S226_Anaerostipes_at
S233_Coprococcus_x_at
S257_Roseburia_x_at
S270_Ruminococcus_at
S270_Ruminococcus_x_at
S348_Ruminococcus_at
S353_Roseburia_at
S487_Clostridium_at
S487_Clostridium_x_at
S494_Roseburia_at
S573_Papillibacter_at
S579_Roseburia_at
S579_Roseburia_x_at
S581_Roseburia_x_at
S599_Lachnobacterium_at
S620_Holdemania_at
S851_Victivallis_at

cross hybridization to other probes
replicate
S051_Clostridium_x_at
S162_Acetivibrio_at
S270_Ruminococcus_at
S336_Ruminococcus_x_at
S807_Prevotella_at
S827_Prevotella_at
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Table 3.3.2 shows the results of the repeat of the experiment where 16S rDNA
from Clostridium sphenoides was used as target. In the second experiment, the target
cross hybridized to only 5 other probes.
We then wanted to see whether the microarray can identify individual species
correctly when all the samples of 16S rDNA were pooled together. 100ng of 16S rDNA
from each species was taken and pooled together. The mixture was fragmented using
0.04 U/µg of DNase I enzyme. The fragmentation product was end labeled with biotin
and then hybridized onto the microarrays.
Table 3.3.3 shows the results of experiments. The microarray correctly identified
15 out of a total of 16 species correctly. Eggerthella lenta was called as absent. Figure
3.3.4 shows the scanned image of the microarray when all the PCR-amplified 16S rDNAs
were pooled together, which shows increased detection sensitivity of the microarray in
terms of the florescence of the probes when compared to the use of total genomic DNA
(Figure 3.2.4).
Later, a negative control experiment was carried out where no DNA sample was
added to hybridization mix. This experiment was important to ensure that the herring
sperm DNA and the control oligonucleotides that are added to the hybridization mix do
not interfere with the actual target DNA sample during the hybridization process.
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Table 3.3.3: Identification of individual species by the microarray when 16S rDNA
from individual species were pooled together
Bacterial species

Amt Det
100ng P
Bifidobacterium longum
100ng P
Bifidobacterium catenulatum
100ng A
Eggerthella lenta
100ng
P
Bacteroides uniformis
100ng P
Bacteroides ovatus
100ng P
Enterococcus faecalis
100ng P
Lactobacillus acidophilus
Ruminococcus albus
100ng P
Clostridium paraputrificum
100ng P
Clostridium difficile
100ng P
Clostridium sordellii
100ng P
Clostridium sphenoides
100ng P
Eubacterium limosum
100ng P
Holdemania filiformis
100ng P
Fusobacterium nucleatum
100ng P
Escherichia coli
Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal

Figure 3.3.4: Scanned image of the microarray when all 16S rDNA samples are
pooled together
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Figure 3.3.5: Negative control experiment where in no DNA sample is added to the
hybridization mixture.

Figure 3.3.5 shows the image of the microarray scanned by the GeneChip 3000
Scanner. The negative control experiment produced significantly lower signal for a
particular probe/species to be called present, indicating that neither the herring sperm
DNA nor the control oligonucleotides that are added to the hybridization mixture
interfere with the actual sample during the hybridization process.

3.4 Detection limit of the Microarray
3.4.1 In the absence of human gDNA
We wanted to find the lowest amount of the nucleic acid sample that can be
detected when hybridized to the microarray. For this, we have chosen only four different
bacterial species, Bifidobacterium longum, Bacteroides uniformis, Lactobacillus
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acidophilus and Clostridium sphenoides. We have chosen only these four species because
these samples had the highest nucleic acid yield.
Total genomic DNA from the above four species was pooled together and
fragmented using 0.075 U/µg of DNase I. A part of the fragmented product was run on a
10% polyacrylamide gel to check that the fragment size was within the desired range.
Then the fragmented product was end labeled with biotin in a terminal transferase
reaction and then hybridized onto the microarray.
Table 3.4.1.1 Detection limit of the microarray when total gDNA was used in the
absence of human gDNA
Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli

Amt Det
10ng
P
A
A
50ng
P
A
A
1ng
A
A
A
A
A
200ng P
A
A
A
A

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal

Above results shows that 10ng of gDNA could be detected by the microarray in
the absence of human gDNA.
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3.4.2 In the presence of human gDNA
The experiment was done in the same way as above, but this time in presence of
human gDNA. The human gDNA isolated from HeLa cells was kindly donated by Dr.
Leffak. All the DNAs were pooled together along with the human DNA. The mixture was
fragmented using 0.075 U/µg of DNase I enzyme. The fragmented product was endlabeled with biotin in a terminal transferase reaction and hybridized onto the microarray.
Table 3.4.2.1 Detection limit of the microarray in presence of human gDNA when
total gDNA was used
Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli
Human gDNA

Amt Det
10ng
P
A
A
50ng
P
A
A
1ng
A
A
A
A
A
200ng P
A
A
A
A
3.74µg P

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal

From the Table 3.4.2.1, it can be seen that the lowest amount that could be
detected by the microarray was 10ng total genomic DNA when used along with human
gDNA. The signal obtained is higher in the experiment where no human gDNA was used
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as compared to the experiment where human gDNA was used. This is thought to be due
to the fact that the amount of human gDNA added is several fold higher in concentration
which is near saturation and this somehow limits the accessibility of the actual target
sequences towards their respective probes. In order to see if we could detect amounts
greater than 1ng but smaller than 10ng when the bacterial total gDNA was used in
presence of human gDNA, we did a new experiment where 4ng each of bacterial gDNAs
were used in addition to 4.0µg of human gDNA. The DNA mixture was fragmented using
0.075 U/µg of DNase I.
Table 3.4.2.2 Detection limit of the microarray in presence of human gDNA
Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli
Human gDNA

Amt Det
4ng
P
A
A
4ng
A
A
A
4ng
P
A
A
A
A
4ng
P
A
A
A
A
4.0µg P

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal
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From the Table 3.4.2.2, it can be seen that in 3 of 4 cases, the microarray could
detect 4ng of sample. Hence, we established the detection limit of the microarray to be at
least 4ng of total unamplified genomic DNA.
3.4.3 Detection limit of the microarray when PCR-amplified 16S rDNA was used
Total gDNA from the previously used four bacterial species was taken in similar
amounts and subjected to 10 cycles of PCR amplification. The amplified product was
fragmented using 0.04 U/µg of DNase I and hybridized onto the microarray.
Table 3.4.3.1 Detection limit when PCR-amplified 16S rDNA was used
No human
gDNA
Bacterial species
Bifidobacterium longum
Bifidobacterium catenulatum
Eggerthella lenta
Bacteroides uniformis
Bacteroides ovatus
Enterococcus faecalis
Lactobacillus acidophilus
Ruminococcus albus
Clostridium paraputrificum
Clostridium difficile
Clostridium sordellii
Clostridium sphenoides
Eubacterium limosum
Holdemania filiformis
Fusobacterium nucleatum
Escherichia coli
Human gDNA

Amt
10ng
50ng
1ng
200ng
-

Det
P
A
A
P
A
A
P
P
A
A
A
P
A
A
A
A
A

Presence of
human
gDNA
Amt
Det
10ng
A
A
A
50ng
P
A
A
1ng
P
A
A
A
A
200ng
P
A
A
A
A
3.74µg P

Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal
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Table 3.4.3.1 summarizes the results of experiments. When amplified 16S rDNA
was used as target, the microarray could detect even 1ng. So, we wanted to see if the
microarray can detect even lower amounts when 16S rDNA was used. Due to problems
with the TAKARA Hot Star DNA polymerase enzyme, all the subsequent amplifications
were performed using Taq 2X MasterMix PCR reaction mixture from NEB. In order to
reduce the variability among the experiments, we pooled the bacterial genomic DNA
with human genomic DNA and carried out the PCR amplifications. Since the amounts of
starting template are very low, we added gDNA of Holdemania filiformis to be able to
visualize the amplified product on the agarose gel. In the first experiment, 10pg each of
Bacteroides

uniformis,

Lactobacillus

acidophilus,

Clostridium

sphenoides

and

Escherichia coli gDNA were pooled together along with 4.0µg of human gDNA. In
another experiment, 1pg each of the above four bacterial gDNAs were pooled together
but no human gDNA was added. In both the experiments, 50ng of Holdemania filiformis
gDNA was used as a control to be able to visualize the amplified product on a gel.
Table 3.4.3.2 Detection limit when 10pg and 1pg of amplified 16S rDNA is used

Bacterial species
Bacteroides uniformis
Lactobacillus acidophilus
Clostridium sphenoides
Holdemania filiformis
Escherichia coli
Human gDNA

In presence of
human gDNA
Amt
Det
10pg
P
10pg
P
10pg
P
50ng
P
10pg
P
4.0µg
P

No human
gDNA
Amt
Det
1pg
P
1pg
P
1pg
P
50ng
P
1pg
M
A

Amt: Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal

44

From the Table 3.4.3.2, it can be seen that the lowest amounts that could be
detected by the microarray were 10pg of amplified 16S rDNA in presence of human
gDNA and 1pg of the PCR-amplified 16S rDNA in absence of human gDNA.

3.5 RNA as starting material
The microarray was designed as antisense type which allows both DNA and RNA
targets to be interrogated and so we wanted to validate the use of total RNA as the
starting material for hybridization. RNA from five bacterial species, Bacteroides
uniformis, Lactobacillus acidophilus, Clostridium sphenoides, Bifidobacterium longum
and Escherichia coli was used. Only these five species were used in particular because
these are the species from which we had highest yields of total RNA.
cDNA synthesis from the RNA mixture was carried out as described in the
standard Affymetrix GeneChip protocol (Appendix I). The resultant end-product was
terminally labeled with biotin and hybridized onto the microarrays. Two replicates were
performed to check for consistency in the detection by the microarray and reproducibility
of the results.
Table 3.5.1 RNA as starting material
1st replicate

2nd replicate

Bacterial species
Amt
Det
Amt
Det
Bifidobacterium longum
100ng
100ng
P
P
100ng
Bacteroides uniformis
100ng
P
P
Lactobacillus acidophilus
100ng
100ng
P
P
Clostridium sphenoides
100ng
100ng
P
P
Escherichia coli
100ng
100ng
P
P
Amt: Amount of gDNA hybridized to chip
Det: Detection P- Present/A-Absent/M-Marginal
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From the above table, it can be seen that all the bacterial species’ RNA has been
detected and the use of RNA as a starting material for hybridization has been successfully
tested. Sensitivity of the microarray was even greater when RNA was used as target.

3.6 Fold change experiments
Fold change experiments were done to examine if the microarray can detect
quantitative changes in the composition of the microflora and try to establish a
relationship between the expected and observed signals. Six bacterial species,
Bifidobacterium longum, Bacteroides uniformis, Lactobacillus acidophilus, Clostridium
sphenoides, Holdemania filiformis and Escherichia coli were used. Of these, the first four
species were used to assess actual fold change experiments and Holdemania filiformis
was used in constant amount in all the experiments to normalize the signal intensities
across all the experiments. E.coli gDNA was used in appropriate amounts to adjust the
total amount of sample hybridized to the chips in each experiment to 1.0µg. 12.5ng to
200ng of the four bacterial species were used in order to provide a 16-fold difference in
the amounts hybridized onto the microarray.
Table 3.6.1 Fold change experiments
Amounts hybridized onto the microarray
Bacterial species
Bifidobacterium longum
Bacteroides uniformis
Lactobacillus acidophilus
Clostridium sphenoides
Holdemania filiformis
Escherichia coli
Total amount on chip

Expt 1
12.5ng
12.5ng
12.5ng
12.5ng
100ng
850ng
1.0µg

Expt 2
25ng
25ng
25ng
25ng
100ng
800ng
1.0µg
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Expt 3
50ng
50ng
50ng
50ng
100ng
700ng
1.0µg

Expt 4
100ng
100ng
100ng
100ng
100ng
500ng
1.0µg

Expt 5
150ng
150ng
150ng
150ng
100ng
300ng
1.0µg

Expt 6
200ng
200ng
200ng
200ng
100ng
100ng
1.0µg

For these experiments, 1.5 µg of each of the four bacterial total gDNA was pooled
together and fragmented. Similarly, 1 µg of gDNA from Holdemania filiformis and 4 µg
of E.coli gDNA were taken and fragmented separately.

Figure 3.6.1 Relationship between expected signal and actual signal ratios
Figure 3.6.1 shows the results of the fold change experiments and the relationship
between the expected signal ratio and the observed signal ratio. The dots in the graph
correspond to the averages of the expected signal and observed signal ratios and it can be
observed that there is a good correspondence between expected and observed signal
values with the R2 (coefficient of determination) value being equal to 0.94 and slope of
the linear trendline equal to 0.79. It can be seen from the above graph that the observed
signal ratios deviate from the expected ratios at higher fold changes. This is thought to
occur because with the increasing fold change the hybridization mixture becomes
saturated with higher amounts of nucleic acid fragments of the same species.
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3.7 Microarray analysis of fecal samples
To know whether the microarray can identify and quantify the various bacterial
species present in fecal samples, four fecal samples were obtained from healthy
volunteers (two adults and two children). DNA was isolated from all the fecal samples
using QIAamp DNA Stool Mini Kit (Qiagen). PCR amplification of 16S rDNA was
carried out from all the samples using the Taq 2X MasterMix from NEB. Three
individual PCR reactions were carried out per each sample so as to reduce the biases, if
any that might occur during the PCR reaction (Polz et al., 1998).
The amplified DNA was fragmented with 0.04U/µg of DNase I enzyme. The
fragmented product was run on a 10% polyacrylamide gel to check the size of the
fragments obtained. The fragmented DNA was end labeled with biotin and then
hybridized onto the microarray. Two replicates were done per each sample.

Figure 3.7.1 1% agarose gel of DNA isolated from two adults and two children
2 µl of each sample is loaded onto gel and A1 and A2 are adult fecal DNAs and C1 and
C2 are child fecal DNA samples.
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Table 3.7.1 Bacteria detected by the microarray in fecal samples at Order level
Child 1
Class
Cyanobacteria
Alphaproteobacteria
Betaproteobacteria
Gammaproteobacteria
Deltaproteobacteria
Epsilonproteobacteria
Clostridia
Mollicutes
Bacilli
Actinobacteria
Spirochaetes
Bacteroidetes
Fusobacteria
Verrucomicrobiae
Lentisphaerae

# Phylo
0
0
4
2
1
0
201
2
7
6
0
26
0
1
0

Signal
0.0%
0.0%
4.3%
2.1%
0.3%
0.0%
79.0%
0.0%
1.1%
0.1%
0.0%
13.0%
0.0%
0.1%
0.0%

Child 2
# Phylo
0
0
0
6
1
0
192
3
2
0
0
33
0
0
1

Signal
0.0%
0.0%
0.0%
8.3%
0.4%
0.0%
80.7%
0.1%
0.1%
0.0%
0.0%
10.4%
0.0%
0.0%
0.0%

Adult 1
# Phylo
0
0
1
0
0
0
168
4
2
1
0
18
0
1
0

Signal
0.0%
0.0%
0.1%
0.0%
0.0%
0.0%
90.7%
0.6%
0.1%
0.0%
0.0%
7.8%
0.0%
0.7%
0.0%

Adult 2
# Phylo
1
0
1
2
1
0
174
2
3
0
1
21
0
1
1

Signal
0.1%
0.0%
0.9%
0.1%
0.3%
0.0%
87.3%
0.1%
0.3%
0.0%
0.0%
8.9%
0.0%
1.9%
0.0%

# Phylo: Number of phylo-species detected for each bacterial class
Signal: % contribution to total signal by phylo-species in each bacterial class

49

The two microarray replicates per each fecal DNA sample had excellent
correlation among them (Pearson correlation coefficient equal to 0.97, 0.99 respectively
for the two child fecal samples and 0.99, 0.97 respectively for the two adult samples)
which indicates excellent reproducibility of the results.
Analysis of the microarray results showed 238, 250 species were called present in
the two child fecal samples and 195, 208 species were called present in the two adult
fecal samples. The above table shows various bacterial classes identified by the
microarray in the four fecal samples analyzed. All the four fecal samples studied were
dominated by the members of Clostridia, which is in accordance with the literature that
Clostridia are the dominant inhabitants of the human intestine. Second highest number of
species of bacteria present next to Clostridia is Bacteroidetes. Adult fecal samples had
higher percentages of Clostridia (87-90%) when compared to the children’s samples (7981%), whereas the two child samples had higher Bacteroidetes when compared to adult
samples (10-13% in child samples, 8-9% in adults). Another important difference is that
children had higher percentages of Proteobacteria when compared to adults (6.7-8.7% in
children, 0.1-1.3% in adults). However, Verrucomicrobiae were present in adults and not
in children. Diversity of the bacterial genera detected was quite similar among all the four
samples- 40 and 43 different genera were detected in child fecal samples, 35-40 genera
were detected amount the adult samples. Among the child fecal samples, at the order
level, there were some differences observed. For example, Burkholderiales was present at
4.3% of the total signal in one child sample, whereas it was completely absent in another
child sample. The two adult fecal samples had similar compositions at the order level.
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At the genus level, the most abundant species in the child samples were
Faecalibacterium, Ruminococcus, and Bacteroides with the contribution being 26, 18,
and 8% to the total signal, respectively. Among the adult samples studied, the dominant
species were Ruminococcus, Papillibacter, and Faecalibacterium with 24, 17 and 8%
(respectively) contribution to the total signal. Roseburia was another genus that is present
in all the four samples analyzed at a relatively similar level (~7% of total signal).

Table 3.7.2 Bacterial species identified in the fecal samples at Family level

Family
Cyanobacteria - F3.1
Rhodobacteraceae
Sphingomonadaceae
Phyllobacteriaceae
Bradyrhizobiaceae
Methylobacteriaceae
Methylocystaceae
Rhodobiaceae
Burkholderiaceae
Oxalobacteraceae
Alcaligenaceae
Neisseriaceae
Xanthomonadaceae
Moraxellaceae
Succinivibrionaceae
Enterobacteriaceae
Pasteurellaceae
Desulfovibrionaceae
Campylobacteraceae
Helicobacteraceae
Clostridiaceae
Lachnospiraceae
Peptostreptococcaceae
Eubacteriaceae
Peptococcaceae

Adult 1
Adult 2
Child 1
Child 2
# Phylo Signal # Phylo Signal # Phylo Signal # Phylo Signal
0
0.0%
1
0.1%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
1
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
1
0.1%
1
0.9%
3
4.2%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
2
0.1%
1
0.0%
5
6.9%
0
0.0%
0
0.0%
1
2.1%
1
1.4%
0
0.0%
1
0.3%
1
0.3%
1
0.4%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
63
36.4%
54
26.9%
68
44.0%
54
36.8%
64
28.3%
83
44.7%
97
24.4% 100 38.0%
0
0.0%
0
0.0%
1
0.0%
0
0.0%
3
0.2%
5
0.6%
8
2.4%
9
1.7%
3
1.0%
2
0.2%
0
0.0%
0
0.0%

51

Acidaminococcaceae
Thermoanaerobacteriaceae
Erysipelotrichaceae
Staphylococcaceae
Turicibacteraceae
Lactobacillaceae
Enterococcaceae
Streptococcaceae
Firmicutes - IS9
Coriobacteriaceae
Actinomycetaceae
Micrococcaceae
Dermabacteraceae
Corynebacteriaceae
Bifidobacteriaceae
Serpulinaceae
Leptospiraceae
Bacteroidaceae
Rikenellaceae
Porphyromonadaceae
Prevotellaceae
Fusobacteriaceae
Fusobacteria - IS11
Verrucomicrobiaceae
Victivallaceae

35
0
4
0
0
0
0
2
0
0
0
0
0
0
1
0
0
11
7
0
0
0
0
1
0

24.8%
0.0%
0.6%
0.0%
0.0%
0.0%
0.0%
0.1%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
4.8%
3.0%
0.0%
0.0%
0.0%
0.0%
0.7%
0.0%

30
0
2
0
0
0
0
2
1
0
0
0
0
0
0
1
0
15
6
0
0
0
0
1
1

14.8%
0.0%
0.1%
0.0%
0.0%
0.0%
0.0%
0.1%
0.2%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
7.3%
1.6%
0.0%
0.0%
0.0%
0.0%
1.9%
0.0%

27
0
2
1
1
0
0
5
0
3
1
0
0
0
2
0
0
17
6
3
0
0
0
1
0

8.1%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
1.0%
0.0%
0.1%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
10.8%
2.0%
0.2%
0.0%
0.0%
0.0%
0.1%
0.0%

27
2
3
0
0
0
0
1
1
0
0
0
0
0
0
0
0
25
6
2
0
0
0
0
1

4.1%
0.1%
0.1%
0.0%
0.0%
0.0%
0.0%
0.0%
0.1%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
9.1%
1.2%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

At the family level, clear differences between the adult and fecal flora were
observed. Members of Clostridiaceae and Lachnospiraceae were present at similar levels
in both adults and children where the members of Acidaminococcaceae were present in
higher amounts (14.8-18.8%) in adults when compared to children (4.1-8.1%).
Pasteurellaceae were present in child fecal samples but were not detected in adult fecal
samples. Bacteroidaceae were present in higher amounts in children (9.1-10.8%) when
compared to adults (4.8-7.3%).
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4. Discussion
This study describes the validation of a high-throughput, custom-made microarray
designed to study the human intestinal microflora. It contains probes that can identify and
quantify the numerous bacterial phylo-species that are believed to reside in the human
intestine. The validation experiments were carried out using 16 different pure bacterial
cultures representing various bacterial phylo-species. The microarray correctly identified
15 out of a total of 16 species. Only Eggerthella lenta was called absent in all the
validation experiments. The 16S rDNA gene was amplified from Eggerthella lenta and
DNA sequencing analysis of the fragment showed that the species belonged to genus
Propionibacterium. The microarray did not contain probes for this bacterium and hence
could not detect them. Members of Propionibacterium commonly live on skin of humans
(Brüggemann et al 2004) and are most common contaminants of bacterial cultures due to
the lack of proper care. Though the experiment turned out to be negative, it represents an
important validation result because it did not randomly produce signal that might have
resulted due to incorrect sequence hybridizations.
Use of PCR-amplified 16S rDNA led to increased sensitivity of the microarray
when compared to the use of total genomic DNA because it produced higher signal.
Cross hybridizations of the target to other probes were low and they have been shown to
be reduced to significant level by the use of replicates.
Other community microarray studies like those performed by Huyghe et al, 2008,
describe the development and validation of a custom-made community microarray, but
we believe our study is better in terms of the quality of the validation experiments done.
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The study by Huyghe et al used only three bacterial species for their validation purposes
and our study used 16 species and hence is more reliable and accurate.
The detection limit of the microarray was 4ng when total genomic DNA was
used in absence of human gDNA and 1ng when 10 cycles of PCR reaction were carried
out to amplify the 16S rDNA. When the PCR cycles were increased to 30, as low as 10
pg of bacterial DNA was detected in presence of human gDNA (represents 0.00025% of
total sample, which represents 4000-fold dynamic range of detection) and 1pg when no
human gDNA was used. To ensure that the microarray can quantitatively compare the
difference in amount of a particular species among different samples, a series of fold
change experiments have been carried out. A good, close-to-linear correspondence was
seen between observed and expected signal intensities.
The design of microarray was carried out as an antisense type allowing both DNA
and RNA to be interrogated. The use of DNA as target has been established and probably
this study is the first to establish that even RNA can be used as a starting material. The
use of RNA as target led to increased sensitivity of the microarray.
Finally, as a test, four fecal samples have been analyzed by the microarray, two
each from children and adults. The microarray identified several bacterial phylo-species
from the fecal samples revealing interesting observations. However, Bifidobacteria,
Lactobacilli, the two genera often used in several probiotic preparations were not
significantly detected in all four samples. This was thought to be due to the universal
primers not being efficient in amplifying the members of both genera. For this purpose, a
modified

forward

primer

Amp_27F_V4

was

designed

(AGRGTTYGATYMTGGCTCAG) which has 4 degenerate positions (the original
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forward primer, Amp_27F had a single degenerate nucleotide position). PCR on fecal
sample from one of the child volunteers was carried out with the new forward primers
(Amp_27F_V4) and the original reverse primer (Univ_1492R) and the product was
fragmented and hybridized onto microarray. It identified seven different phylo-species of
Bifidobacteria. But the signal was not high when compared to other members of the
microflora. This was consistent with the study of Palmer et al, who also showed lower
amounts of bifidobacteria in adults and children. The detection of Lactobacilli was not
improved even with the use of new primers indicating absence of species in the samples
or that they are below the threshold of detection even though they are present.
Future work includes the use of this custom microarray to examine clinical
samples of patients suffering from intestinal disorders like inflammatory bowel disease,
irritable bowel syndrome, Crohn’s disease and colon cancer to obtain information about
the composition of the microflora and its changes during diseased condition. The
information obtained from these studies can help in development of a suitable treatment
strategy and also decrease chances of mis-diagnosis which happens quite often because of
the symptom overlap with other common gastro-intestinal ailments.
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APPENDIX I
Protocol for cDNA synthesis from total RNA
1. Prepare the following mixture

Components

Volume

Total RNA

As required

75 ng/µl Random primers

10 µl

Nuclease – free H2O

up to 30 µl

Total Volume

30 µl

2. Incubate the RNA primer mix at the following temperatures
a. 700C for 10 minutes
b. 250C for 10 minutes
c. Chill to 40C
3. Prepare the following cDNA synthesis reaction mixture
Components

Volume

RNA primer hybridization mix from previous step

30 µl

5X 1st Strand buffer

12 µl

100mM DTT

6 µl

10mM dNTPs

3 µl

SUPERase (20U/ µl)

1.5 µl

SuperScript II (200U/ µl)

7.5 µl

Total volume

60 µl

4. Incubate the reaction mixture as follows
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a. 250C for 10 minutes
b. 370C for 60 minutes
c. 420C for 60 minutes
d. Inactivate SuperScript II at 700C for 10 minutes
e. Chill to 40C
5. Remove the RNA by adding 20 µl of 1N NaOH and incubate for 650C for 30 minutes
followed by addition of 20 µl of 1N HCl to neutralize.
6. Purify the cDNA by Qiagen MinElute PCR Purification Columns.

The resultant cDNA can now be fragmented using 0.6 U/µg of cDNA. The
fragmented product is now ready to be terminally labeled with biotin in a terminal
transferase reaction as followsComponents
Volume
5X Reaction buffer
10 µl
GeneChip DNA labeling reagent
2 µl
Terminal deoxynucleotidyl transferase
2 µl
Fragmented cDNA product
up to 20 µl
Nuclease-free H2O
16 µl
Total volume
50 µl

Incubate the above reaction mixture at 370C for 60 minutes. Add 2 µl of 0.5M EDTA
to stop the labeling reaction. The labeled product is ready to be hybridized onto the
microarrays. Prepare the hybridization mixture as followsComponents
2X Hybridization buffer
3nM B2 Control oligo
10 mg/ml Herring Sperm DNA
50 mg/ml BSA
100% DMSO
Fragmented and labeled cDNA product
Molecular biology grade water
Total volume
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Volume
65 µl
2.2 µl
1.3 µl
1.3 µl
10.2 µl
up to 50 µl
130 µl

APPENDIX II
PCR Reaction protocol
1. 940C for 30 seconds
2. 980C for 10 seconds
3. 550C for 15 seconds
4. 720C for 90 seconds
5. Repeat Step 2 as per the number of cycles required
6. 40C for ever
7. End
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APPENDIX III
2-log DNA ladder
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